Literature DB >> 15257900

[Effect of XK469 and adriamycin on the growth of H460 cells in vitro and its mechanism].

Zhao-hui Ling1, Hua Du, Chang-qing Yuan, Shu-dong Ma, Li Zheng, Zhen-hua Ding.   

Abstract

OBJECTIVE: To investigate the inhibitory effect of XK469 on the in vitro growth of H460 cells and its mechanism.
METHODS: The survival curves of H460 cells treated with XK469, XN472 and adriamycin, respectively, were obtained by MTT analysis, and the effect of XK469 and adriamycin on the cell cycle of H460 cells examined by flow cytometry. Western blotting was adopted for detecting the expression of cdc2 and phos-cdc2 induced by XK469 and adriamycin.
RESULTS: Different concentrations of XK469 and adriamycin could significantly inhibit the growth of H460 cells, induce their G2/M phase arrest, and increase phos-cdc2 expression; XN472 had a lesser effect on the growth of H460 cells.
CONCLUSION: XK469 can increase phos-cdc2 expression and induce G2/M phase cell cycle arrest of H460 cells, resulting in inhibition of H460 cell growth. The inhibitory effect of XK469 on H460 cell growth is attributed to the chlorine in the 7-positon of its structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257900

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  2 in total

1.  The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80.

Authors:  David Kessel; John J Reiners; Stuart T Hazeldine; Lisa Polin; Jerome P Horwitz
Journal:  Mol Cancer Ther       Date:  2007-01       Impact factor: 6.261

2.  The chemotherapeutic agents XK469 (2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid) and SH80 (2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid) inhibit cytokinesis and promote polyploidy and induce senescence.

Authors:  John J Reiners; Miriam Kleinman; Aby Joiakim; Patricia A Mathieu
Journal:  J Pharmacol Exp Ther       Date:  2008-12-09       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.